BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32186813)

  • 1. [Vertigo as the first manifestation of ovarian cancer].
    Weiland MTD; van Oosterhout WPJ; Bakker SD
    Ned Tijdschr Geneeskd; 2020 Feb; 164():. PubMed ID: 32186813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.
    Saeed DB; Gupta L
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma.
    Negishi Y; Sakai K; Noguchi Y; Iwasaki N; Kawai N
    J Obstet Gynaecol Res; 2014 Feb; 40(2):614-7. PubMed ID: 24148073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic cerebellar degeneration in a woman with ovarian cancer.
    Santillan A; Bristow RE
    Nat Clin Pract Oncol; 2006 Feb; 3(2):108-12; quiz 1 p following 112. PubMed ID: 16462852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic cerebellar degeneration secondary to ovarian carcinosarcoma: a cerebellar conundrum.
    Birch JD; Sen A; Rowland K; Viner T
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28790096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic cerebellar degeneration as the first evidence of cancer: a case report.
    Liu S; Tunkel R; Lachmann E; Nagler W
    Arch Phys Med Rehabil; 2000 Jun; 81(6):834-6. PubMed ID: 10857534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paraneoplastic cerebellar degeneration as the presenting manifestation of breast carcinoma: a case report].
    Chaabane K; Turki E; Zouari F; Charfi S; Guermazi M; Mhiri C
    Rev Med Interne; 2013 Nov; 34(11):713-5. PubMed ID: 24367813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VGCC antibody-positive paraneoplastic cerebellar degeneration presenting with positioning vertigo.
    Ogawa E; Sakakibara R; Kawashima K; Yoshida T; Kishi M; Tateno F; Kataoka M; Kawashima T; Yamamoto M
    Neurol Sci; 2011 Dec; 32(6):1209-12. PubMed ID: 21678073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer revealed by paraneoplastic cerebellar degeneration: a case report.
    Elomrani F; Ouziane I; Boutayeb S; Bensouda Y; Mrabti H; Errihani H
    Pan Afr Med J; 2014; 18():2. PubMed ID: 25360186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Paraneoplastic neurologic degeneration revealing ovarian cancer recurrence].
    Zouiten O; Benbrahim Z; Amaadour L; Mellas N
    Pan Afr Med J; 2019; 33():281. PubMed ID: 31692829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian mass Presenting as Paraneoplastic cerebellar degeneration with peripheral neuropathy and anti-Yo antibody.
    Sahoo D; Dey A; Dash A; Dash A
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Paraneoplastic subacute cerebellar degeneration: case report].
    Bardy FB; Cagy M; Pompeu Filho F; Lamarca JE; Rabinovitz M; Godoy JM
    Arq Neuropsiquiatr; 2000 Sep; 58(3A):764-8. PubMed ID: 10973125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Yo paraneoplastic cerebellar degeneration in a patient with stage IV ovarian adenocarcinoma during bevacizumab maintenance therapy.
    Giucca A; Morrison H; Wilson T; Cossburn M
    BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37137547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.
    Imai T; Shinohara K; Uchino K; Okuma H; Maki F; Hiruma K; Ariizumi Y; Yamano Y
    BMC Neurol; 2022 May; 22(1):165. PubMed ID: 35501715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic cerebellar degeneration as the first manifestation of cancer.
    Lin JT; Lachmann E; Nagler W
    J Womens Health Gend Based Med; 2001 Jun; 10(5):495-502. PubMed ID: 11445049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated ZIC4 antibodies in paraneoplastic cerebellar syndrome with an underlying ovarian tumor.
    Kerasnoudis A; Rockhoff M; Federlein J; Gold R; Krogias C
    Arch Neurol; 2011 Aug; 68(8):1073. PubMed ID: 21825246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration.
    Forgy AP; Ewing TL; Flaningam J
    Gynecol Oncol; 2001 Jan; 80(1):96-8. PubMed ID: 11136578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic cerebellar degeneration mimicking development of secondary progressive multiple sclerosis in a patient with relapsing-remitting multiple sclerosis.
    Gracien R; Kordulla M; Ziemann U
    Mult Scler; 2011 Apr; 17(4):498-500. PubMed ID: 21148018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Ri-associated paraneoplastic brainstem cerebellar syndrome with coexisting limbic encephalitis in a patient with mixed large cell neuroendocrine lung carcinoma.
    Mitchell AN; Bakhos CT; Zimmerman EA
    J Clin Neurosci; 2015 Feb; 22(2):421-3. PubMed ID: 25443085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.